← Back to Search

Procedure

1 for Interleukins

Phase 3
Waitlist Available
Led By Dennis Hong, MD., MS.c, FRCSC
Research Sponsored by Legacy Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
undergoing laparoscopic gastric bypass, >18 yo, understands english
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

To see if removing the omentum in addition to a gastric bypass improves diabetes is better than just a gastric bypass.

Eligible Conditions
  • Diabetes
  • Interleukins
  • Cytokines

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
diabetic indices
Secondary outcome measures
interleukin and cytokine levels, weight loss

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
surgery plus omentectomy
Group II: 2Active Control1 Intervention
standard gastric bypass

Find a Location

Who is running the clinical trial?

Legacy Health SystemLead Sponsor
35 Previous Clinical Trials
3,641 Total Patients Enrolled
Dennis Hong, MD., MS.c, FRCSCPrincipal InvestigatorOregon Weight Loss Surgery, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025